You are here:

The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial.

Lassen P et al. Radiother Oncol. 2011 Mar 21.

Lassen P, Eriksen JG, Krogdahl A, Therkildsen MH, Ulhøi BP, Overgaard M, Specht L, Andersen E, Johansen J, Andersen LJ, Grau C, Overgaard J
Radiotherapy and Oncology
Radiother Oncol. 2011 Mar 21.

Link PubMed